Synthesis, characterization and in vitro activity of a surface-attached antimicrobial cationic peptide

Biofouling

Volumn 25, Issue 6, 2009, Pages 517-524

  Chen, Renxun ^a   Cole, Nerida ^a,b,c   Willcox, Mark D P ^a,b,c   Park, Josephine ^a   Rasul, Riaz ^a   Carter, Elizabeth ^d   Kumar, Naresh ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b BRIEN HOLDEN VISION INSTITUTE   (Australia)

^c VISION COOPERATIVE RESEARCH CENTRE   (Australia)

^d UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Antimicrobial cationic peptides; Biomaterial; Pseudomonas; Staphylococcus

Indexed keywords

ADHESION; ANTIBIOTICS; ANTIMICROBIAL ACTIVITY; BACTERIUM; BIOASSAY; CATION; COLONIZATION; FLUORESCENCE SPECTROSCOPY; INFECTIVITY; MORPHOLOGY; PEPTIDE; SCANNING ELECTRON MICROSCOPY; X-RAY SPECTROSCOPY;

BACTERIA (MICROORGANISMS); PSEUDOMONAS; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS;

4 AZIDOBENZOIC ACID; 4 FLUORO 3 NITROPHENYL AZIDE; 4-AZIDOBENZOIC ACID; 4-FLUORO-3-NITROPHENYL AZIDE; ANTIMICROBIAL CATIONIC PEPTIDE; AZIDE; BIOMATERIAL; MELIMINE;

ARTICLE; BACTERIUM ADHERENCE; CHEMICAL STRUCTURE; CHEMISTRY; CYTOLOGY; DRUG EFFECT; GROWTH, DEVELOPMENT AND AGING; MATERIALS TESTING; METABOLISM; METHODOLOGY; PSEUDOMONAS AERUGINOSA; SPECTROSCOPY; STAPHYLOCOCCUS AUREUS; SURFACE PROPERTY; SYNTHESIS; ULTRASTRUCTURE;

ANTIMICROBIAL CATIONIC PEPTIDES; AZIDES; BACTERIAL ADHESION; COATED MATERIALS, BIOCOMPATIBLE; MATERIALS TESTING; MOLECULAR STRUCTURE; PSEUDOMONAS AERUGINOSA; SPECTRUM ANALYSIS; STAPHYLOCOCCUS AUREUS; SURFACE PROPERTIES;

EID: 67650273311     PISSN: 08927014     EISSN: 10292454     Source Type: Journal    
DOI: 10.1080/08927010902954207     Document Type: Article

References (37)

1. Bach A, Darby D, Bottiger B, Bohrer H, Motsch J, Martin E. 1996. Retention of the antibiotic teicoplanin on a hydromer-coated central venous catheter to prevent bacterial colonization in postoperative surgical patients.Int Care Med 22:1066-1069.
2. Barraud N, Hassett DJ, Hwang S-H, Rice SA, Kjelleberg S, Webb JS. 2006. Involvement of nitric oxide in biofilm dispersal of Pseudomonas aeruginosa. J Bacteriol 188:7244-7353.
3. Bonde M, Pontoppidan H, Pepper DS. 1992. Direct dye binding - a quantitative assay for solid-phase immobilized protein. Anal Biochem 200:195-198.
4. Bong JJ, Kite P, Wilco MH, McMahon MJ. 2003. Prevention of catheter related bloodstream infection by silver iontophoretic central venous catheters: a randomized controlled trial. J Clin Pathol 56:731-735.
5. Bryers JD, Jarvis RA, Lebo J, Prudencio A, Kyriakides TR, Uhrich K. 2006. Biodegradation of poly(anhydrideesters) into non-steroidal anti-inflammatory drugs and their effect on Pseudomonas aeruginosa biofilms in vitro and on the foreign-body response in vivo. Biomaterials 27:5039-5048.
6. Ciresi DL, Albrecht RM, Volkers PA, Scholten DJ. 1996. Failure of antiseptic bonding to prevent central venous catheter-related infection and sepsis. Am Surg 62:641-646.
7. Darouiche RO, Raad II, Heard SO, Thornby JI, Wenker OC, Gabrielli A, Berg J, Khardori N, Hanna H, Hachem R, et al. 1999. A comparison of two antimicrobialimpregnated central venous catheters. N Engl J Med 340:1-8.
8. Fleet GWJ, Knowles JR, Porter RR. 1972. The antibody binding site. Labelling of a specific antibody against the photo-precursor of an aryl nitrene. Biochem J 128:499-508.
9. Grabarek Z, Gergely J. 1990. Zero-length crosslinking procedure with the use of active esters. Anal Biochem 185:131-135.
10. Gristina AG. 1987. Biomaterial-centered infection: microbial adhesion versus tissue integration. Science 237:1588-1595.
11. Guire P, Klaus M. 1976. Photochemical immobilization of enzymes and other biochemicals. Methods Enzymol 44:280-288.
12. Harmer MA. 1991. Photomodification of surfaces using heterocyclic azides. Langmuir 7:2010-2012.
13. Inamori K, Kyo M, Matsukawa K, Inoue Y, Sonoda T, Tatematsu K, Tanizawa K, Mori T, Katayama Y. 2008.Optimal surface chemistry for peptide immobilization in on-chip phosphorylation analysis. Anal Chem 80:643-650.
14. Jones JR, Ehrenfried LM, Saravanapavan P, Hench LL. 2006. Controlling ion release from bioactive glass foam scaffolds with antibacterial properties. J Mater Sci Mater Med 17:989-996.
15. Kamal GD, Pfaller MA, Rempe LE, Jebson PJ. 1991. Reduced intravascular catheter infection by antibiotic bonding. A prospective, randomized, controlled trial. JAMA 265:2364-2368.
16. Kirov SM, Webb JS, O'May CY, Reid DW, Woo JKK, Rice SA, Kjelleberg S. 2007. Biofilm differentiation and dispersal in mucoid Pseudomonas aeruginosa isolates from patients with cystic fibrosis. Microbiology 153:3264-3274.
17. Klotz S. 1990. Role of hydrophobic interactions in microbial adhesion to plastics used in medical devices. In: Doye RJ, Rosenberg M, editors. Microbial cell surface hydrophobicity. Washington (DC): American Society for Microbiology. p. 107-135.
18. Knowles JR, Fleet GW, Porter RR. 1969. Affinity labeling of antibodies with aryl nitrene as reactive group. Nature 224:511-512.
19. Lam PK, Chan ES, Ho WS, Liew CT. 2004. In vitro cytotoxicity testing of a nanocrystalline silver dressing (Acticoat) on cultured keratinocytes. Br J Biomed Sci 61:125-127.
20. Leung D, Spratt DA, Pratten J, Gulabivala K, Mordan NJ, Young AM. 2005. Chlorhexidine-releasing methacrylate dental composite materials. Biomaterials 26:7145-7153.
21. Madkour AE, Tew GN. 2008. Towards self-sterilizing medical devices: controlling infection. Polymer Int 57:6-10.
22. Maki DG, Cobb L, Garman JK, Shapiro JM, Ringer M, Helgerson RB. 1988. An attachable silver-impregnated cuff for prevention of infection with central venous catheters: a prospective randomised multicenter trial. Am J Med 85:307-314.
23. Mermel LA. 2000. Prevention of intravascular catheterrelated infections. Ann Intern Med 132:391-402.
24. Nahar P, Wali NM, Gandhi RP. 2001. Light-induced activation of an inert surface for covalent immobilization of a protein ligand. Anal Biochem 294:148-153.
25. Nelson CL. 1979. Environmental bacteriology in the unidirectional (horizontal) operating room. Arch Surg 114:778-782.
26. Neu HC. 1992. The crisis in antibiotic resistance. Science 257:1064-1073.
27. Rasband WS.1997-2008. ImageJ software. National Institutes of Health, Bethesda, Maryland, USA; [cited 2008 June 18]. Available from: http://rsb.info.nih.gov/ij/
28. Ravikumar T, Murata H, Koepsel RR, Russell AJ. 2006. Surface-active antifungal polyquaternary amine. Biomacromolecules 7:2762-2769.
29. Rusmini F, Zhong Z, Feijen J. 2007. Protein immobilization strategies for protein biochips. Biomacromolecules 8:1775-1789.
30. Schierholz JM, Beuth J. 2001. Implant infections: a haven for opportunistic bacteria. J Hosp Infect 49:87-93.
31. SmithAW.2005. Biofilms and antibiotic therapy: is there a role for combating bacterial resistance by the use of novel drug delivery systems? Adv Drug Deliv Rev 57:1539-1550.
32. Stocks SM. 2004. Mechanism and use of the commercially available viability stain, BacLight. Cytometry Part A 61:189-195.
33. Thornton J, Todd NJ, Webster NR. 1996. Central venous line sepsis in the intensive care unit. A study comparing antibiotic coated catheters with plain catheters. Anaesthesia 51:1018-1020.
34. Willcox MDP, Hume EBH, Cole N, Aliwarga Y, Zanini D. 2004. Biomedical devices with antimicrobial coatings. US Patent Application 2004126409.
35. Willcox MDP, Hume EBH, Aliwarga Y, Kumar N, Cole N. 2008. A novel cationic-peptide coating for the prevention of microbial colonization on contact lenses. J Appl Microbiol 105:1817-1825.
36. Williams TJ, Schneider RP, Willcox MDP. 2003. The effect of protein-coated contact lenses on the adhesion and viability of Gram negative bacteria. Curr Eye Res 27:227-235.
37. Wu P, Grainger DW. 2006. Drug/device combinations for local drug therapies and infection prophylaxis. Biomaterials 27:2450-2467.